As per NAVADHI Market Research, the global pharmaceutical industry
will we worth USD 1.57 trillion by 2023.
Merck & Co., Inc. is a global health care company that delivers
innovative health solutions through its prescription medicines, vaccines,
biologic therapies and animal health products. The Company’s operations are
principally managed on a products basis and include four operating segments,
which are the Pharmaceutical, Animal Health, Healthcare Services and Alliances
segments.
The Pharmaceutical segment includes human health pharmaceutical and
vaccine products. Human health pharmaceutical products consist of therapeutic
and preventive agents, generally sold by prescription, for the treatment of
human disorders. The Company sells these human health pharmaceutical products
primarily to drug wholesalers and retailers, hospitals, government agencies and
managed health care providers such as health maintenance organizations,
pharmacy benefit managers and other institutions. Vaccine products consist of
preventive pediatric, adolescent and adult vaccines, primarily administered at
physician offices. The Company sells these human health vaccines primarily to
physicians, wholesalers, physician distributors and government entities.
Merck reported revenue of USD 42.294 billion for the FY 2018 which saw
an increase of 5.41% compared to FY 2017. This revenue is expected to increase
by 5.68% and reach USD 44.700 billion by FY 2019.
Merck & Co., Inc. registered highest revenue from oncology
(Keytruda, Emend, Temodar, Alliance revenue – Lynparza and Alliance revenue -
Lenvima) at USD 8.243 billion which accounted for 21.87% of its total
pharmaceuticals sales in FY 2018.
Looking into 2019, Merck said it sees non-GAAP earnings of between
$4.57 and $4.72 per share on worldwide sales of between $43.2 billion and $44.7
billion.
Spanning over 29 pages and 13 exhibits, “Merck & Co., Inc -
Company Snapshot & SWOT Analysis” report provides value chain analysis,
financial performance, business strategy and SWOT analysis for company.
Scope of the Merck & Co., Inc - Company Snapshot & SWOT
Analysis Report
- This report provides detailed information about Merck & Co., Inc
including value chain analysis, financial performance, business strategy and
SWOT analysis.
- The report identifies the growth drivers and inhibitors for global
pharmaceutical market.
- This report provides information about current and future trends for
global pharmaceutical market.
For more details visit: https://www.marketresearchreports.com/navadhi/merck-co-inc-company-snapshot-swot-analysis
Browse more on Pharma andHealthcare Market Research Reports
Read our Interactive Market Research Blog
About NAVADHI Market
Research Pvt Ltd.
NAVADHI is a market research
company that helps global firms differentiate themselves, break market entry
barriers, track their investments, develop business strategies and plan for
future by providing actionable market research intelligence that helps them succeed.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.